Latest Articles

Publication Date
Op-ed: Building better standards in women's health through measurement - Fierce Healthcare

Op-ed: Building better standards in women's health through measurement Fierce Healthcare

Published: Nov. 21, 2025, 3:30 p.m.
Common fertility myths that can mislead women’s health choices - Healthcare Radius

Common fertility myths that can mislead women’s health choices Healthcare Radius

Published: Nov. 21, 2025, 5:37 a.m.
Online randomised e-hypnotherapy for chronic pelvic pain study (REST): comparing e-hypnotherapy with relaxation and waitlist to improve pain, cost-effectiveness and biopsychosocial outcomes.

Chronic pelvic pain, defined as persistent pain in the structures of the pelvis, is a condition that significantly impacts the health-related quality of life (HRQoL) of up to one-third of …

Published: Nov. 19, 2025, midnight
Lack of Scientific Evidence for the Use of Gestrinone in the Treatment of Lipedema: A Systematic Review.

Lipedema is a chronic, progressive disorder marked by the abnormal accumulation of subcutaneous adipose tissue, predominantly in the lower body and almost exclusively affecting women. In recent years, the off-label …

Published: Nov. 19, 2025, midnight
Delays in Endometriosis Diagnosis: A Healthcare Perspective - Bioengineer.org

Delays in Endometriosis Diagnosis: A Healthcare Perspective Bioengineer.org

Published: Nov. 18, 2025, 5:41 p.m.
Exploring delay to diagnosis of endometriosis, a healthcare professional perspective.

Published: Nov. 18, 2025, midnight
Australia to open 11 endometriosis, pelvic pain clinics - Healthcare Asia Magazine

Australia to open 11 endometriosis, pelvic pain clinics Healthcare Asia Magazine

Published: Nov. 17, 2025, 2:58 a.m.
Cannabidiol and ∆9-Tetrahydrocannabinol in Endometriosis: A Literature Review on Therapeutic Applications and Mechanisms.

Endometriosis is a chronic, inflammatory, and multifactorial disease characterized by the presence of endometrial tissue outside the uterine cavity, often associated with debilitating symptoms. It affects approximately 10% of women …

Published: Nov. 17, 2025, midnight
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare

FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare

Published: Nov. 13, 2025, 6:17 a.m.
How Women with Endometriosis Use Social Media for Support and Self-Management: An Analysis of Reddit Content.

Women with endometriosis often experience insufficient knowledge and support regarding their condition within the healthcare system. Women use social media to obtain information, share personal experiences, and establish connections with …

Published: Nov. 11, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!